HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C Négrier Selected Research

anti-inhibitor coagulant complex

5/2015FEIBA in the treatment of acquired haemophilia A: results from the prospective multicentre French 'FEIBA dans l'hémophilie A acquise' (FEIBHAC) registry.
9/2013Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA study.
5/2013SURgical interventions with FEIBA (SURF): international registry of surgery in haemophilia patients with inhibitory antibodies.
3/2013Consensus recommendations for the use of FEIBA(®) in haemophilia A patients with inhibitors undergoing elective orthopaedic and non-orthopaedic surgery.
1/2011Identifying non-responsive bleeding episodes in patients with haemophilia and inhibitors: a consensus definition.
7/2006A retrospective postlicensure survey of FEIBA efficacy and safety.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C Négrier Research Topics

Disease

11Hemophilia A (Haemophilia)
09/2017 - 04/2000
10Hemorrhage
01/2016 - 04/2000
5Hemophilia B (Haemophilia B)
07/2016 - 01/2002
4Thrombasthenia (Glanzmann Thrombasthenia)
07/2004 - 05/2000
3Afibrinogenemia (Fibrinogen Deficiency)
02/2018 - 09/2008
1von Willebrand Diseases (von Willebrand's Disease)
02/2018
1Vomiting
11/2016
1Cough
11/2016
1Exanthema (Rash)
11/2016
1Headache (Headaches)
11/2016
1Urticaria (Hives)
11/2016
1Chills
11/2016
1Drug-Related Side Effects and Adverse Reactions
11/2016
1Arteriovenous Fistula
05/2013
1Rheumatoid Arthritis
09/2012
1Thrombosis (Thrombus)
07/2004
1Liver Diseases (Liver Disease)
01/2002
1Thrombocytopenia (Thrombopenia)
04/2000
1Liver Failure
04/2000

Drug/Important Bio-Agent (IBA)

6Factor VIII (Coagulation Factor VIII)IBA
09/2017 - 01/2002
6anti-inhibitor coagulant complexIBA
05/2015 - 07/2006
5recombinant FVIIa (rFVIIa)FDA Link
01/2011 - 04/2000
4Fibrinogen (Factor I)FDA Link
02/2018 - 01/2002
3Factor IX (Coagulation Factor IX)FDA LinkGeneric
07/2016 - 03/2002
3AntibodiesIBA
05/2013 - 05/2000
3Glycoproteins (Glycoprotein)IBA
07/2004 - 05/2000
3Platelet Membrane Glycoprotein IIbIBA
07/2004 - 05/2000
3Pharmaceutical PreparationsIBA
07/2004 - 04/2000
2Factor VIIa (Activated Factor VII)IBA
01/2011 - 04/2000
2recombinant factor VIII SQIBA
07/2007 - 09/2004
1CollagenIBA
02/2018
1recombinant factor VIII N8IBA
09/2017
1AlbuminsIBA
07/2016
1Recombinant Fusion ProteinsIBA
07/2016
1Proteins (Proteins, Gene)FDA Link
07/2016
1AntigensIBA
01/2016
1EpitopesIBA
01/2016
1Therapeutic UsesIBA
06/2013
1Warfarin (Coumadin)FDA LinkGeneric
06/2013
1CytokinesIBA
09/2012
1lipoprotein-associated coagulation inhibitor (TFPI)IBA
09/2012
1ThrombomodulinIBA
09/2012
1Antifibrinolytic Agents (Antifibrinolytics)IBA
07/2004
1Heparin (Liquaemin)FDA LinkGeneric
01/2002
1Vitamin KFDA Link
01/2002

Therapy/Procedure

7Therapeutics
01/2016 - 04/2000
4Operative Surgical Procedures
07/2016 - 03/2013
3Platelet Transfusion (Blood Platelet Transfusions)
07/2004 - 05/2000
1Injections
07/2016
1Minor Surgical Procedures (Minor Surgery)
03/2013
1Intravenous Infusions
07/2007
1Erythrocyte Transfusion
09/2004